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The genome of Australian strain 002-73 of infectious bursal disease virus (IBDV) has been cloned as cDNA 
fragments into an expression library based on pUR plasmid vectors. Recombinant colonies were selected 
with a monoclonal antibody specific for the 32-kDa host-protective immunogen of IBDV and fully charac- 
terized by nucleotide sequence analysis. The amino acid sequence of several tryptic peptides derived from 
the native 32-kDa structural protein has confirmed the coding region assignment and nucleotide sequence 
data. We believe this to be the first published sequence of a birnavirus-encoded protein and these data may 
provide the basis for an effective subunit vaccine against IBDV 
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1. INTRODUCTION 
IBDV can establish a highly contagious disease 
in young chickens that causes severe im- 
munodepression due to destruction of developing 
&lymphocytes in the bursa of Fabricus [l] and 
results in significant commercial losses to the 
poultry industry [2,3]. The current production 
strategy for an inactivated vaccine is expensive, 
labour intensive and subject to considerable batch 
variation [3,4]. Thus a subunit vaccine produced 
by recombinant DNA techniques could provide an 
effective and inexpensive alternative method for 
the control of this commercially important disease. 
The sequence data contained in this paper will be sub- 
mitted to both databases 
Abbreviations: Mab, monoclonal antibody; IBDV, in- 
fectious bursal disease virus; NBRF, the protein se- 
quence database of the National Biomedical Research 
Foundation, Washington, USA; GENBANK, the 
nucleotide sequence database of the Los Alamos Na- 
tional Laboratory, Los Alamos, USA 
The genome of the Australian IBDV strain 
(002-73) consists of two segments of double- 
stranded RNA [5] typical of the small family of 
birnaviruses [6]. The larger RNA segment compris- 
ing about 3400 bp has been shown to encode the 
two major structural proteins estimated at 37 and 
32 kDa [5]. Of these, the 32-kDa protein is the 
most likely target for the production of a subunit 
vaccine since the purified protein when injected in- 
to chickens produces antibodies capable of both 
neutralizing the virus in vitro and affording passive 
protection [7]. 
2. EXPERIMENTAL 
2.1. Molecular cloning of the expression library 
Techniques for colony hybridization, isolation 
of plasmid DNA, production of hybridization 
probes and the generation of a recombinant cDNA 
library from IBDV genomic RNA into the plasmid 
vector pBR322 have been described [S]. cDNA in- 
serts, still containing homopolymeric dG/dC tails, 
were subcloned into pUR expression vectors [8] 
and screened with monoclonal antibodies as 
described [9]. 
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2.2. Nucleotide sequence analysis 
Modifications were made to both the chemical 
degradation technique [lo] and the dideoxy chain 
termination method [ll]. Plasmids were end- 
labelled at the EcoRI or Hind111 sites as described 
[ 121. Chemical degradation [lo] then enables the 
nucleotide sequence to be obtained directly over 
the dG/dC tails into the cDNA structure and 
allows the reading phase to be determined in either 
pUR 290, 291 or 292. Specific internal cDNA se- 
quences were obtained by a similar cleavage and 
end-labelling strategy. As an alternative method 
the dG/dC homopolymeric tails were removed us- 
ing Ba131 exonuclease and the cDNA inserts then 
cloned into the M13mplO vector and sequenced 
[l I] but with modifications that improved 
transcription fidelity over regions of secondary 
structure in the template. These included removal 
of NaCl from the buffer, using reverse transcrip- 
tase and optimized ratios of dideoxy : deox- 
ynucleotides (1: 30A; 2 : 15C; 1: 15G; 2 : 3T) and 
performing the reaction at 30°C or greater. 
Nucleotide sequences were compiled using a 
VAX/VMS computer system using the program- 
mes described previously [ 131. 
2.3. Amino acid sequence analysis 
The IBDV 32-kDa protein [5] was excised and 
electroeluted from SDS-polyacrylamide gels by the 
method described in [14]. Purified protein was 
then digested with 2% (w/w) TPCK trypsin for 4 h 
at 37°C in 0.05 M NI&HCOs, the solution dried 
and the residue redissolved in 0.1% trifluoroacetic 
acid. Peptides were purified by high-pressure 
liquid chromatography [15] and manually se- 
quenced [ 161 using previously described modifica- 
tions [15]. 
3. RESULTS AND DISCUSSION 
3.1. Characterization of expressing clones 
An IBDV cDNA library was constructed in 
pBR322 [5] and shown to contain over 100 unique 
recombinants with overlapping cDNA inserts that 
spanned the IBDV genome. These cDNA inserts 
were subcloned into a pUR expression library of 
several hundred recombinants and screened with a 
monoclonal antibody (Mab-80) specific for the 
denatured form of the IBDV 32-kDa structural 
protein [9]. Two immunopositive clones were iden- 
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tified in the library, designated as Dl containing an 
insert of approx. 450 bp and D6 of approx. 
1000 bp. Using the cDNA inserts from Dl and D6 
as probes, four recombinants were selected from 
the original library [5] to generate a number of 
overlapping cDNA fragments which spanned this 
region of the IBDV genome. The cDNA map of 
the IBDV genome [5] together with a summarized 
sequencing strategy is presented in fig.1, Each 
residue in the nucleotide sequence presented in 
fig.2 was confirmed from at least two overlapping 
sequencing runs. The sequence was compiled from 
a number of independent cDNA clones and these 
provided a check on the fidelity of cDNA synthesis 
during the construction and amplification of the 
cDNA libraries. There were no point mutations, 
deletions or rearrangements found in the cDNA in- 
serts thus confirming that the method of random- 
primed cDNA synthesis [5] was remarkably error- 
free. 
3.2. Primary structure of the 32-kDa immunogen 
The fusion proteins expressed by Dl and D6 
clones were estimated to be 120 and 140 kDa in 
size, respectively, by polyacrylamide gel analysis 
[9]. From the nucleotide sequence the fusion pro- 
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Fig.1. Sequencing strategy and map of the large RNA 
segment of IBDV. Overlapping cDNA clones designated 
M7 to D6 have been previously mapped by cross- 
hybridization [5]. The region spanning clones Dl and D6 
have been expanded and show restriction sites for EcoRI 
(E), BumHI (B), Hind111 (H), HpaII (P), NcoI (N), 
ApaI (A), f3gnI (G). Chemical sequencing [lo] was 
performed on cDNA fragments end-labelled at suitable 
restriction sites and the sequence runs are shown as 
arrowed lines. Dideoxy sequencing I1 l] was performed 
on Bu131 exonuclease-treated cDNA fragments of C2 
and D6 subcloned into Ml3 to confirm overlapping 
sequences (not shown). 
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Fig.2. Sequence analysis of the Dl and D6 expression clones. The predicted amino acid sequence is presented in single 
letter code above the nucleotide sequence derived from the cDNA clones. There are no other extensive open reading 
frames. Both nucleotide and amino acid sequences are numbered sequentially from position 1, and the region 
encompassed by Dl (residues 146-294) is indicated. Dibasic residues 20-21 are boxed and thirteen N-terminal sequences 
obtained from tryptic peptides are indicated by dashed lines. 
teins were shown to consist of an IBDV-encoded 
peptide (shown in fig.2) fused to the C-terminus of 
,f?-galactosidase via a polyglycine sequence derived 
from the homopolymeric dG/dC tails. The 
nucleotide sequence also established that both Dl 
and D6 expressed fusion proteins in the same 
translation reading phase. The 310 residue peptide 
encoded by the cDNA insert of D6 had a predicted 
molecular mass of 34.7 kDa ending with the 
IBDV-encoded termination codon and thus 
spanned the IBDV 32-kDa antigen. N-terminal se- 
quences of thirteen tryptic peptides (fig.2) con- 
firmed the predicted reading phase in the Dl and 
D6 clones. The native 32-kDa protein when ex- 
tracted from the virus could not be sequenced 
directly by Edman degradation due to a blocked N- 
terminal residue. However, the N-terminus of the 
32-kDa protein can be predicted to be near residue 
21 (fig.2), given the calculated molecular mass and 
the termination codon after residue 310 defining 
the carboxyl-terminus. 
It appears likely that the 32-kDa protein is 
generated by proteolysis of a larger precursor 
molecule perhaps at the Lys-Arg dibasic sequence 
(residues 20-21) since this would generate a pro- 
tein (residues 22-3 10) with a molecular mass of 
32.5 kDa. Further protein characterization on the 
small amounts of structural and precursor proteins 
145 
Volume 201, number 1 FEBS LETTERS May 1986 
extracted from the native virus will be needed to 
resolve the precise N-terminus of the 32-kDa 
protein. 
There appears to be no significant homology to 
any other protein or nucleotide listed in the NBRF 
or GENBANK databases. We believe our data on 
the IBDV 32-kDa protein to be the first reported 
sequence of a birnavirus structural antigen. Pep- 
tides are currently being synthesized corresponding 
to the strongest hydrophilic region (residues 
146-161) for the peptide based vaccine strategy 
[ 171. Alternatively we are constructing novel high- 
yield vectors capable of expressing various regions 
of the IBDV genome in bacterial or yeast cells for 
use as a vaccine. 
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